Stocks Health care ANGO

NASDAQ · Health care

Angiodynamics Inc (ANGO)

Angiodynamics Inc reported revenue of $320.2M in fiscal 2026, up 9.5% from a year earlier. It posted a net loss of $36.7M. Operating cash flow minus capital spending left $508K of free cash flow in fiscal 2026. At May 31, 2026 it held $53.9M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on July 14, 2026.

What Angiodynamics Inc does

Angiodynamics Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ANGO.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where ANGO ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Angiodynamics Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. July 14, 2026
   Annual report 10-K · period to May 31, 2026
2. July 14, 2026
   Quarterly results 8-K
3. May 15, 2026
   Passive stake changed SCHEDULE 13G/A
4. April 23, 2026
   Other event 8-K
5. April 2, 2026
   Quarterly report 10-Q · period to February 28, 2026
6. April 2, 2026
   Quarterly results 8-K
7. March 26, 2026
   Passive stake changed SCHEDULE 13G/A
8. February 13, 2026
   Passive stake changed SCHEDULE 13G/A
9. February 10, 2026
   Passive stake (5% or more) SCHEDULE 13G
10. February 9, 2026
    Passive stake (5% or more) SCHEDULE 13G

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 31, 2026. Insider transactions on SEC

What is ANGO worth? A DCF from its reported cash flow

Insider trades

What the people running Angiodynamics Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about ANGO

What does Angiodynamics Inc do?

Angiodynamics Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ANGO.

Is Angiodynamics Inc profitable?

No. In fiscal 2026 it reported a net loss of $36.7M on revenue of $320.2M.

How much revenue does Angiodynamics Inc make?

In fiscal 2026 Angiodynamics Inc reported revenue of $320.2M. That is 9.5% more than a year earlier.

When did Angiodynamics Inc last report?

Its most recent periodic report is the annual report (10-K) filed on July 14, 2026. It covers the period to May 31, 2026. Its newest filing of any kind is the insider trade from July 31, 2026.

Similar companies

Compare ANGO with

Compare ANGO with any company

Follow ANGO

Get an email when Angiodynamics Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow ANGO: get an email when it files

Where the numbers come from

Financial figures are the values Angiodynamics Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.